Difficulties in Defining Oligometastatic Prostate Cancer: Implications for Clinical Trial Accrual and Community Practice Adoption of Metastasis-Directed Therapy Approaches

Background: Metastasis-directed therapy is widely utilized for oligometastatic prostate cancer patients, but standard imaging does not always identify metastases definitively and, even with PSMA PET, there may be equivocal findings. Not all clinicians have access to detailed imaging review, particul...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorff, Tanya Barauskas, Kasparian, Saro, Garg, Natasha, Liu, Sandy, Pal, Sumanta Kumar, Wong, Jeffrey, Dandapani, Savita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004229/
https://www.ncbi.nlm.nih.gov/pubmed/36902798
http://dx.doi.org/10.3390/jcm12052011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004229/
https://www.ncbi.nlm.nih.gov/pubmed/36902798
http://dx.doi.org/10.3390/jcm12052011

Ejemplares similares